An NSF International Company FDA Draft Guidance on Specification of the UFI System for Drug Establishments
Monday the 16th September 2013
The FDA has published draft guidance on the “Specification of the Unique Facility Identifier (UFI) System for Drug Establishment Registration”. This draft states that the FDA’s preferred UFI for a drug establishment is the Data Universal Numbering System D-U-N-S (DUNS) number, assigned and managed by Dun and Bradstreet.
The FDA has been using the DUNS number as a registration number for drug establishments since the implementation of electronic drug registration and listing.
